Christian Sutter
Overview
Explore the profile of Christian Sutter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
5720
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirsch S, Rahmanzade R, Grund K, Sutter C, Schramm K, Selt F, et al.
Acta Neuropathol
. 2025 Mar;
149(1):25.
PMID: 40085243
No abstract available.
2.
Li S, Madanat-Harjuoja L, Leslie G, Barnes D, Bolla M, Dennis J, et al.
J Natl Cancer Inst
. 2024 Nov;
PMID: 39585318
Background: Whether carriers of BRCA1 or BRCA2 (BRCA1/2) pathogenic variants (PVs) have increased risks of childhood, adolescent, and young adult (CAYA) cancers is controversial. We aimed to evaluate this risk...
3.
Barnes D, Tyrer J, Dennis J, Leslie G, Bolla M, Lush M, et al.
medRxiv
. 2024 Mar;
PMID: 38496424
Background: Nineteen genomic regions have been associated with high-grade serous ovarian cancer (HGSOC). We used data from the Ovarian Cancer Association Consortium (OCAC), Consortium of Investigators of Modifiers of (CIMBA),...
4.
Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology
Sturm D, Capper D, Andreiuolo F, Gessi M, Kolsche C, Reinhardt A, et al.
Nat Med
. 2023 Oct;
30(1):306.
PMID: 37875569
No abstract available.
5.
Ahmad O, Sutter C, Hirsch S, Pfister S, Schaaf C
Hered Cancer Clin Pract
. 2023 Jul;
21(1):11.
PMID: 37400873
A founder variant is a genetic alteration, that is inherited from a common ancestor together with a surrounding chromosomal segment, and is observed at a high frequency in a defined...
6.
Kolodziejczak A, Guerrini-Rousseau L, Planchon J, Ecker J, Selt F, Mynarek M, et al.
Neuro Oncol
. 2023 Jun;
25(12):2273-2286.
PMID: 37379234
Background: The prognosis for Li-Fraumeni syndrome (LFS) patients with medulloblastoma (MB) is poor. Comprehensive clinical data for this patient group is lacking, challenging the development of novel therapeutic strategies. Here,...
7.
Ecker J, Selt F, Sturm D, Sill M, Korshunov A, Hirsch S, et al.
Eur J Cancer
. 2023 Mar;
184:200-201.
PMID: 36959034
No abstract available.
8.
Sturm D, Capper D, Andreiuolo F, Gessi M, Kolsche C, Reinhardt A, et al.
Nat Med
. 2023 Mar;
29(4):917-926.
PMID: 36928815
The large diversity of central nervous system (CNS) tumor types in children and adolescents results in disparate patient outcomes and renders accurate diagnosis challenging. In this study, we prospectively integrated...
9.
Ecker J, Selt F, Sturm D, Sill M, Korshunov A, Hirsch S, et al.
Eur J Cancer
. 2022 Dec;
180:71-84.
PMID: 36542877
Background: Precision oncology requires diagnostic accuracy and robust detection of actionable alterations. The Pediatric Targeted Therapy (PTT) 2.0 program aims at improving diagnostic accuracy by addition of molecular analyses to...
10.
Hakkaart C, Pearson J, Marquart L, Dennis J, Wiggins G, Barnes D, et al.
Commun Biol
. 2022 Oct;
5(1):1061.
PMID: 36203093
The contribution of germline copy number variants (CNVs) to risk of developing cancer in individuals with pathogenic BRCA1 or BRCA2 variants remains relatively unknown. We conducted the largest genome-wide analysis...